|
Zimvie complaint number (b)(6).The following fields have been updated: b4: date of this report.B5: describe event or problem.G3: date received by manufacturer.G6: type of report.H1: type of reportable event.H2: follow up type.H3: device evaluated by manufacturer.H6: adverse event problem.H10: additional narrative.Zimvie received one (1) xifosm385, (osseotite® certain® 2 implant 3.25 x 8.5mm) for evaluation.Visual evaluation of the as returned device identified the implant with signs of use, minor bone / tissue attached to external threads.The alleged reported implant fracture was not identified.Functional testing to recreate the reported events could not be performed due to the nature of the device & events.Dhr review was completed for the subject lot number 2120007064.No deviations or non-conformances, which could have caused or contributed to the reported events, were noted as part of the dhr.Complaint history review was performed for the reported lot number 2120007064 for similar events and no other complaint was identified.Review completed utilizing keywords: ¿fracture implant¿ & ¿non-integration infection¿ a definitive root cause could not be determined since the device malfunction did not occur, and the reported event (fracture implant) has been unconfirmed following visual and physical evaluation.Refer to attached summary investigation for ¿infection¿ therefore, based on the available information, a device malfunction did not occur.The reported event (fracture implant) was unconfirmed with all the available information.Non-integration infection is a medical condition and is non-verifiable with the information provided.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the products were nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.Similar complaints for implant infection have been previously investigated.Refer to attached summary investigation.Visual and dimensional evaluations of the previously returned product have not identified or suggested manufacturing non-conformances.While non-conformances were identified for some lots during manufacturing record reviews, the documented disposition actions for each did not suggest the likely release of non-conforming product.Zimvie quality management system (qms) has controls in place to ensure the distribution of conforming product.Additionally, all device history record reviews verified that each implant was sterilized per procedure for every device.All complaint data used for the summary investigation was found to be conforming and did not meet capa/hhe/d/ or any further escalations.Therefore, there were no complaints which confirmed a manufacturing or design related issue that did or could cause or contribute to the reported event.At this time, the complaint investigation has been completed and the record will be closed.If additional information is received, the record will be re-opened for further evaluation.
|